Vivid Wealth Management LLC boosted its stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON – Free Report) by 6.0% during the third quarter, Holdings Channel reports. The fund owned 7,154 shares of the biotechnology company’s stock after acquiring an additional 407 shares during the period. Axon Enterprise makes up approximately 1.5% of Vivid Wealth Management LLC’s holdings, making the stock its 19th biggest holding. Vivid Wealth Management LLC’s holdings in Axon Enterprise were worth $2,859,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in AXON. Motley Fool Asset Management LLC lifted its stake in shares of Axon Enterprise by 238.7% during the first quarter. Motley Fool Asset Management LLC now owns 492,140 shares of the biotechnology company’s stock valued at $153,981,000 after acquiring an additional 346,838 shares during the period. 1832 Asset Management L.P. acquired a new position in Axon Enterprise during the 1st quarter valued at about $81,630,000. International Assets Investment Management LLC bought a new position in shares of Axon Enterprise in the 3rd quarter valued at about $871,860,000. Vanguard Group Inc. grew its position in shares of Axon Enterprise by 2.7% during the 1st quarter. Vanguard Group Inc. now owns 8,143,306 shares of the biotechnology company’s stock worth $2,547,878,000 after buying an additional 212,401 shares during the period. Finally, Swedbank AB bought a new stake in shares of Axon Enterprise during the first quarter worth approximately $39,923,000. Institutional investors and hedge funds own 79.08% of the company’s stock.
Insider Buying and Selling
In other news, President Joshua Isner sold 25,811 shares of Axon Enterprise stock in a transaction that occurred on Tuesday, September 10th. The shares were sold at an average price of $359.84, for a total value of $9,287,830.24. Following the sale, the president now directly owns 228,166 shares in the company, valued at $82,103,253.44. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. In other news, President Joshua Isner sold 25,811 shares of the stock in a transaction dated Tuesday, September 10th. The shares were sold at an average price of $359.84, for a total transaction of $9,287,830.24. Following the completion of the transaction, the president now directly owns 228,166 shares in the company, valued at $82,103,253.44. This represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, CEO Patrick W. Smith sold 80,300 shares of Axon Enterprise stock in a transaction dated Friday, August 23rd. The shares were sold at an average price of $371.78, for a total value of $29,853,934.00. Following the completion of the sale, the chief executive officer now directly owns 3,015,366 shares in the company, valued at approximately $1,121,052,771.48. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders sold 371,172 shares of company stock worth $137,000,162. 5.70% of the stock is owned by corporate insiders.
Axon Enterprise Stock Up 0.1 %
Axon Enterprise (NASDAQ:AXON – Get Free Report) last announced its earnings results on Tuesday, August 6th. The biotechnology company reported $1.20 earnings per share for the quarter, topping analysts’ consensus estimates of $1.02 by $0.18. Axon Enterprise had a net margin of 16.06% and a return on equity of 9.34%. The firm had revenue of $504.00 million during the quarter, compared to analyst estimates of $478.35 million. During the same period in the prior year, the business earned $0.80 EPS. The company’s revenue for the quarter was up 34.5% compared to the same quarter last year. Research analysts predict that Axon Enterprise, Inc. will post 1.79 earnings per share for the current year.
Analyst Ratings Changes
AXON has been the topic of a number of recent research reports. Robert W. Baird raised their price objective on shares of Axon Enterprise from $360.00 to $400.00 and gave the company an “outperform” rating in a research note on Tuesday, September 10th. Craig Hallum upped their price objective on Axon Enterprise from $370.00 to $376.00 and gave the company a “buy” rating in a report on Wednesday, August 7th. Barclays raised their target price on Axon Enterprise from $381.00 to $387.00 and gave the stock an “overweight” rating in a report on Wednesday, August 7th. JMP Securities upped their price target on Axon Enterprise from $375.00 to $430.00 and gave the company an “outperform” rating in a research note on Thursday, September 12th. Finally, Northland Securities increased their price target on shares of Axon Enterprise from $330.00 to $365.00 and gave the company an “outperform” rating in a research report on Thursday, August 8th. Two analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $382.85.
About Axon Enterprise
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
Featured Articles
- Five stocks we like better than Axon Enterprise
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Inflation Risk Rising, Key Trades Investors Are Making Now
- How to Calculate Retirement Income: MarketBeat’s Calculator
- 3 Oil Stocks to Watch Before Earnings Come Out
- Golden Cross Stocks: Pattern, Examples and Charts
- Is American Express Stock’s Sell-the-News Reaction a Buying Opp?
Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc. (NASDAQ:AXON – Free Report).
Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.